摘要
目的探讨视网膜光凝联合口服碘剂(沃丽汀)治疗糖尿病视网膜病变(DR)的有效性和安全性。方法对50例DR患者应用视网膜光凝联合口服碘剂治疗,观察其疗效及副作用。结果沃丽汀对治疗玻璃体出血有明显疗效,对眼底出血的吸收疗效尤为明显,由于玻璃体混浊、眼底出血及/或视网膜渗出的吸收,大约25.3%的患者用药后提高了视力。不良反应方面,本组患者使用3个月,只有1例患者发生了轻度的胃肠不适,不良反应的发生率2%。结论沃丽汀是一种安全有效的促进玻璃体混浊、视网膜渗出及出血吸收的药物。联合视网膜光凝治疗DR疗效确切。
Objective To investigave the safety and efficacy of using retinal laser and Lincorice-lecithin Bound Iodine (LBD) as the treatment for diabetic retinopathy. Methods 50 patients with diabetic retionopathy were enrolled . LBD were taken orally as well as pan-retinal photocongulation were applied. Results LBD and retinal laser were effective treatment for vitreous hemorrage in the patients of diabetic retinopathy. Visual aculity were improved in 31% patients. There was no systemic side effect expects for only one patient with mild gastrointestinal tract reponses. Incidence of side reaction was 2%. Conclusion LBD was effective and safe in the treatment for vitreous opacity and retinal exudation and hemorrage. Retinal laser combining LBD were valid in the treatment of diabetic retinopathy.
出处
《临床眼科杂志》
2008年第5期411-412,共2页
Journal of Clinical Ophthalmology